to induce mammary and colon adenocarcinomas in F344 rats when adminstered in diet. IQ and MeIQx cause tumors in The N-hydroxylation of carcinogenic arylamines represents liver, lung, Zymbal's gland, and other sites in F344 rats. IQ an initial step in their metabolic activation. Animal studies has also been shown to be a hepatocarcinogen in non-human have shown that this reaction is catalyzed by the cytochrome primates (15).
P450 (P450) enzymes P450 1A1 and P450 1A2. In this
Heterocyclic and aromatic amines, as many other chemical study, utilizing enzymes expressed in Escherichia coli (and carcinogens, require metabolic activation to convert them to purified) or in human B-lymphoblastoid cells, the catalytic genotoxic products. The in vitro metabolism and activation of activities of recombinant human P450 1A1, P450 1A2, and these chemicals have been studied in several animal species, P450 3A4 for N-hydroxylation of several carcinogenic both with microsomal preparations and purified enzymes in arylamines were determined. P450 1A2 from both expres- which recombinant human P450 1A2 has been shown to Furafylline and fluvoxamine, inhibitors of P450 1A2 activity catalyze the mutagenic activation of IQ, MeIQx, PhIP, and in human liver microsomes, were found to be inhibitory of other heterocyclic amines (23,27,28). However, only one study the recombinant P450 1A2 N-hydroxylation activity. Results has provided direct demonstration of purified human P450 from this study are supportive of a major role for human 1A2 catalyzing the N-hydroxylation of an arylamine (29) . In P450 1A2 in the metabolic activation of arylamines.
the present study, we have utilized recombinant human P450 enzymes to establish directly the role of individual P450s in the N-hydroxylation of these carcinogenic arylamines and to The activation and detoxification of chemical carcinogens by provide support for this activation pathway in humans. cytochrome P450 (P450*) enzymes have been extensively Radiolabelled ABP (2,2Ј-3 H; 32 mCi/mmol), IQ (ringstudied (1,2). There is considerable evidence that variations in 3 H; 74 mCi/mmol), and PhIP (ring-3 H; 13.5 Ci/mmol) were the levels of P450s in experimental animals can influence obtained from ChemSyn Science Laboratories (Lenexa, KS). tumor formation since the relative rates of metabolic activation [2-14 C]MeIQx was acquired from Toronto Research Chemicals and/or detoxification of carcinogens can be critical determin-(Ontario, Canada). Furafylline was purchased from Ultrafine ants in tumor induction (1, 3) . Levels of expression of different Chemicals (Manchester, England), and fluvoxamine was kindly human P450 enzymes differ considerably among individuals, donated by Solvay Duphar (Weesp, The Netherlands). Other and there has been much interest in evaluating the influence chemicals were commercially obtained and of HPLC or analytof these differences in risk to potential carcinogens (1, (3) (4) (5) .
ical grade. Human P450 1A1 (30), P450 1A2 (31), and P450 As a means of understanding the relationship between P450s 3A4 (32, 33) were expressed in Escherichia coli, purified, and and cancer in humans, the roles of individual P450 enzymes reconstituted as previously described. cDNA recombinant in the metabolism of carcinogens need to be identified.
human P450 1A1 (M111b, lot 6) and P450 1A2 (M103c, lot The importance of aromatic amines, including heterocyclic 15) were purchased from Gentest (Woburn, MA). These amines, in the etiology of human cancer is of growing interest enzymes were expressed in B-lymphoblastoid cells and (6). Most heterocyclic amines formed during the normal obtained as microsomal preparations. A microsomal preparacooking of meat products have been shown to be strong tion from control cells (M101a, lot 16) was also purchased. NADPH-cytochrome c (P450) reductase was prepared as tion (35) . Cytochrome b 5 was purified as described elsewhere it was less for PhIP.
c Rate of 4'-hydroxylation.
In contrast to results observed with P450 1A2, the 1A1 d nd, not determined.
enzyme was not found to catalyze the N-hydroxylation of the arylamines included in this study (Table I ). The one exception was the N-hydroxylation of PhIP with enzyme expressed in (35) . P450 concentrations were estimated by the method of Omura and Sato (36) . For the cDNA-expressed enzyme E.coli; however, the rate was much lower than that observed with P450 1A2. Our results are consistent with those found preparations purchased from Gentest, the amount of P450 was assumed to be that asserted by the manufacturer. when these two enzymes were compared for their ability to catalyze the activation of heterocyclic amines to mutagens Enzyme assays with purified recombinant P450s (0.5-1.0 nmol P450/ml) were conducted with 0.10 mM arylamine (23,27). Recombinant human P450 1A1 was a much less effective catalyst for IQ and MeIQx than P450 1A2; with PhIP substrate or a range of substrate concentrations (0.0025, 0.005, 0.01, 0.025, 0.05, 0.1, 0.25, 0.5 mM) and 1.0 mM NADPH.
its efficiency is reported to be lower but only 50% less active. The human enzyme may differ with that of rat or rabbit at Incubation mixtures for assaying microsomal preparations of P450s obtained from Gentest contained a NADPH-generating least with respect to the substrate PhIP. Purified rat liver P450 1A1 was found to catalyze the N-hydroxylation of PhIP at a system and 0.10 mM arylamine substrate. Incubations were done at 37°C for 10 min. For each of these assay procedures rate similar to that of purified P450 1A2 (17), and the purified enzyme from rabbit was a more effective catalyst in activating the reaction was terminated by the addition of 1 vol of methanol and analyzed by HPLC (22) . Kinetic parameters (K m this substrate than the purified 1A2 enzyme (18). However, with 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) purified and V max ) for N-hydroxylation were determined by fitting the data to the Michaelis-Menten equation using the program rabbit P450 1A1 was reported to be 25 times less active than P450 1A2 in converting this substrate to a mutagen in the ORIGIN (Microcal Software, Inc., Northampton, MA). For inhibition experiments, furafylline or fluvoxamine was added Ames test (38) . The ability of P450 3A4 to catalyze the Nhydroxylation of arylamines was also examined in the present at various concentrations to the incubation mixtures prior to initiation of the reaction.
study. This enzyme is the most abundant P450 in human liver (39) . N-Hydroxylation activity by P450 3A4 was not observed Metabolic assays were conducted with ABP, IQ, MeIQx, or PhIP and microsomal preparations of human P450 enzymes with any of the arylamines examined (Table I ). The ability of this enzyme to activate several of these amines in mutagenic which were expressed in human B-lymphoblastoid cells or purified enzymes which were expressed in E.coli. At a substrate assays has also been shown to be limited (27, 40) . Metabolic activation activity for the enzyme in microsomes from human concentration of 0.1 mM, P450 1A2 from both expression systems was found to catalyze the N-hydroxylation of each of gastrointestinal tract has been reported but only at low levels (38) . the arylamines at significant rates. Rates of N-hydroxylation of ABP and the heterocyclic amines with enzyme expressed
In more extensive experiments with purified P450 1A2 and varying substrate concentrations, kinetic parameters (K m and in either system were similar (Table I) . With P450 1A2 expressed in E.coli, the values ranged from 1.1 (Ϯ 0.1) nmol/ V max ) for the N-hydroxylation of several arylamines were determined (Table II) . MeIQx was not included because the min/nmol P450 to 3.8 (Ϯ 0.5) nmol/min/nmol P450. The range with enzyme expressed in B-lymphoblastoid cells was 2.0 (Ϯ specific activity of our radiolabelled sample was too low to permit measurement of the N-hydroxy product at low substrate 0.1) nmol/min/nmol P450 to 7.8 (Ϯ 1.0) nmol/min/nmol P450. Interestingly, the rate of N-oxidation of ABP (1.4 nmol/min/ concentrations. The K m values for ABP (30 µM), IQ (33 µM), and PhIP (46 µM) were similar. Values for V max were also nmol P450) catalyzed by P450 1A2 purified from human liver was similar in value (29) . Similarity in the rates of N-oxidation similar (1.8-4.2 nmol/min/nmol P450). The K m value for the N-hydroxylation of PhIP is consistent with the value (55 µM) of these arylamine substrates was also found when assays were conducted with human hepatic microsomes from the previously observed with human liver microsomes (26) . Since furafylline (41) and fluvoxamine (42) have been same individual (22) . Rates of N-oxidation of PhIP with microsomes from human liver have also been determined in shown to be inhibitory to P450 1A2 activity in humans, the K i values of these inhibitors with the purified recombinant at least two other studies (26, 37) . These values were somewhat lower but a wide interindividual variation in N-hydroxy-PhIP P450 1A2 enzyme were, therefore, assessed. N-Hydroxylation
Human cytochrome P450 enzymes activating heterocyclic amines to mutagenic products compared with other P450 enzymes (27, 40) . Support is thereby provided for the P4501A2-catalyzed N-hydroxylation activation pathway in humans implicated by other studies (22, 23, 26, 48) and further suggesting that individual levels of P450 1A2 play a major role in determining risk to the carcinogenicity of these arylamines.
food-borne heterocyclic amine carcinogens. Enzyme expressed which human P4501A2 was a much more effective catalyst in
